Abbott Laboratories (ABT) Gross Margin (2009 - 2026)

Abbott Laboratories has disclosed Gross Margin across 18 years of filings, most recently posting 56.2% for Q1 2026.

• Gross Margin for Q1 2026 came in at 56.2%, down 67.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 56.26% (up 45.0% YoY), and the FY2025 annual result was 56.42%, up 101.0% from the prior year.
• Gross Margin came in at 56.2% for Q1 2026 at Abbott Laboratories, down from 57.05% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 58.07% in Q1 2022 to a low of 54.48% in Q4 2022.
• The 5-year median for Gross Margin is 55.57% (2023), against an average of 55.8%.
• Peak annual rise in Gross Margin reached 457 bps in 2022, while the deepest fall reached 399 bps in 2022.
• Abbott Laboratories' Gross Margin stood at 54.48% in 2022, then advanced by 2 bps to 55.51% in 2023, then decreased by 1 bps to 54.97% in 2024, then advanced by 4 bps to 57.05% in 2025, then decreased by 1 bps to 56.2% in 2026.
• The last three Gross Margin figures came in at 56.2% (Q1 2026), 57.05% (Q4 2025), and 55.36% (Q3 2025), per Business Quant data.